Clinical trial · Interventional
Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Major surgeries including gynecological cancer surgery can make surgical stress that leads to increased burden of postoperative complications, delayed length of hospital stay and increased mortality rate. Protein is one of the essential factors that contribute to the recovery of patients following surgery, as the surgical process increases protein breakdown in the body. Providing patients with an adequate amount of protein helps enhance muscle building, aids in muscle repair, and reduces postoperative inflammation. One study administered a fluid containing a combination of whey protein and carbohydrates to cancer patients in preoperative and postoperative periods. The result of the study shows that intervention group can reduce the length of hospital stay and postoperative complications. However, studies focusing on the use of only-protein supplement to improve surgical complications in gynecological cancer patients are limited. This study aims to investigate the administration of protein supplement before and after surgery in gynecological cancer patients its contribution to the reduction of length of hospital stay and postoperative complications at Rajavithi Hospital.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gynecological Cancer Surgery | — | UNRESOLVED | — |
| Postoperative Outcomes | — | UNRESOLVED | — |
| Whey Protein | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| whey protein supplement | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- whey protein supplement
- description
- Participants are given lactose-free Isolated whey protein 23 gm (containing with whey protein isolate 98.7 % ,Soya lecithin 1.3 % ) which mixed with water 350 ml at 6 p.m prior to surgery and 6.00 a.m. at first day after post surgery
- interventionNames
- Dietary Supplement: whey protein supplement
- type
- NO_INTERVENTION
- label
- standard operative care
- description
- Participants followed standard operative care
Primary outcomes (1)
- measure
- Length of post-operative hospital stay
- timeFrame
- an average of 3 days after operation
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 1. A Woman who suspected or diagnosed with ovarian and endometrial Cancer 2. A Woman who candidates for elective Surgical staging of Laparotomy operation in Rajavithi hospital 3. Aged 18-70 years old 4. Can communicate and understand Thai language very well 5. A woman voluntarily participated in the research Exclusion Criteria: 1. Allergy to whey protein and protein product such as cow milk and egg 2. A Woman who diagnosed with Hypertension, Diabetes Mellitus, Chronic Kidney Disease, Heart disease and Chronic liver disease 3. A Woman who expected difficult operation such as severe pelvic adhesion or required other surgeon for co-evaluation 4. Pregnant woman or breastfeeding 5. A Woman who denied surgery 6. A Woman who currently take a protein supplement 7. A Woman who take Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) , Bisphosphonates, Levodopa ,Tetracycline and Quinolone
References
Publications (0)
Data not yet available